Washington 2023-2024 Regular Session Status: Passed Senate 5 D cosponsors

SB 5629 — Concerning hepatitis B and hepatitis C screening and health care services.

Last action — By resolution, returned to Senate Rules Committee for third reading.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2023-2024 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

209 added · 81 removed

Plain-language change summary

The updated version of SB 5629 now requires health care clinics to offer hepatitis B and C screening tests specifically during annual physical examinations or wellness visits for adult patients. This is a shift from the previous version, which mandated that primary care providers offer these tests to any patient receiving care, regardless of the context. This change is significant because it allows clinics to focus on routine check-ups to identify at-risk patients, ensuring that screenings happen in a more structured and preventive setting, thereby enhancing patient care and public health outcomes.

→
Previous
Latest
S-0460.1 SENATE BILL 5629 State of Washington 68th Legislature 2023 Regular Session By Senators Conway, Dhingra, Hasegawa, Nobles, and C.
ENGROSSED SENATE BILL 5629 State of Washington 68th Legislature 2023 Regular Session By Senators Conway, Dhingra, Hasegawa, Nobles, and C.
and adding a new section to chapter 18.130 RCW.
amending RCW 43.70.613;
adding a new section to chapter 70.54 RCW;
adding a new section to chapter 43.70 RCW;
and providing an expiration date.
A new section is added to chapter 18.130 RCW to read as follows:
A new section is added to chapter 70.54 RCW to read as follows:
(1) Except as provided in subsection (2) of this section, primary care providers shall offer a hepatitis B screening test and a hepatitis C screening test to any patient receiving patient care services, to the extent these services are covered under the patient's health insurance, based on the latest screening indications recommended by the United States preventive services task force.
(1) Except as provided in subsection (2) of this section, an adult patient who receives primary care services from a health care clinic where primary care services are provided shall be offered a hepatitis B screening test and a hepatitis C screening test during an annual physical examination or wellness visit based on the latest screening indications recommended by the federal centers for disease control and prevention.
(2) A hepatitis B screening test and a hepatitis C screening test are not required to be offered by the primary care provider if the primary care provider reasonably believes that:
A health care clinic where primary care services are provided may comply with this subsection by:
(a) Offering patients that meet the recommended screening indications a hepatitis B screening test and a hepatitis C screening test during an annual physical examination or wellness visit;
(b) Incorporating a prompt for hepatitis B screening tests and hepatitis C screening tests for the recommended populations into the health care clinic's electronic health record system;
or p.
1 ESB 5629 (c) Sending routine mailers or electronic communications to the health care clinic's primary care patients that meet the recommended screening indications informing patients of the availability and importance of hepatitis B screening tests and hepatitis C screening tests.
(2) A hepatitis B screening test and a hepatitis C screening test are not required to be offered by the health care clinic if:
(b) The patient has previously been offered or has been the subject of a hepatitis B screening test or hepatitis C screening test, unless the primary care provider determines that one or both of the screening tests should be offered again;
(b) The patient has previously been offered or has been the subject of a hepatitis B screening test or a hepatitis C screening test, unless a health care provider within the health care clinic determines that one or both of the screening tests should be offered again;
or (c) The patient lacks capacity to consent to a hepatitis B screening test or a hepatitis C screening test, or both.
(3)(a) If the patient accepts the offer of the hepatitis B screening test and the test is hepatitis B surface antigen positive, the health care provider within the health care clinic shall offer the patient follow-up health care or refer the patient to another health care provider who can provide follow-up health care.
(b) If a patient accepts the offer of the hepatitis C screening test and the test is positive, the health care provider within the health care clinic shall offer the patient follow-up health care or refer the patient to another health care provider who can provide follow-up health care.
The follow-up health care shall include a hepatitis C diagnostic test.
(4) The offering of a hepatitis B screening test and a hepatitis C screening test under this section must be culturally and linguistically appropriate.
(5) This section does not affect the scope of practice of any health care provider or diminish any authority or legal or professional obligation of any health care provider to offer a hepatitis B screening test, hepatitis C screening test, or both, or a hepatitis C diagnostic test, or to provide services or care for the patient of a hepatitis B screening test, hepatitis C screening test, or both, or a hepatitis C diagnostic test.
(6) A health care provider or health care clinic where primary care services are provided that fails to comply with the requirements of this section shall not be subject to any actions related to their p.
2 ESB 5629 licensure or certification, or to any civil or criminal liability, because of the health care clinic's failure to comply with the requirements of this section.
(7) The department may adopt rules necessary to implement this section and any additional rules involving the offering of screening tests and treatment requirements for hepatitis B and hepatitis C and the training for health care clinics and health care providers.
(8) For purposes of this section:
(a) "Follow-up health care" includes providing medical management and antiviral treatment for chronic hepatitis B or hepatitis C according to the latest national clinical practice guidelines recommended by the American association for the study of liver diseases.
(b) "Health care clinic where primary care services are provided" means an unlicensed health care clinic and any other health care setting where primary care services are provided.
(c) "Hepatitis B screening test" includes any laboratory test or tests that detect the presence of hepatitis B surface antigen and provides confirmation of whether the patient has a chronic hepatitis B infection.
(d) "Hepatitis C diagnostic test" includes any laboratory test or tests that detect the presence of the hepatitis C virus in the blood and provides confirmation of whether the patient has an active hepatitis C virus infection.
(e) "Hepatitis C screening test" includes any laboratory screening test or tests that detect the presence of hepatitis C virus antibodies in the blood and provides confirmation of whether the patient has ever been infected with the hepatitis C virus.
NEW SECTION.
Sec.
2.
A new section is added to chapter 43.70 RCW to read as follows:
(1) By September 1, 2025, and subject to the availability of amounts appropriated for this specific purpose, the department shall design a hepatitis B and a hepatitis C awareness campaign for the public and primary care providers.
The department shall collaborate with health care providers and community-based organizations that serve high risk patients and patient groups that historically have lacked health care coverage or access to consistent primary care services.
1 SB 5629 (c) The patient lacks capacity to consent to a hepatitis B screening test or hepatitis C screening test, or both;
3 ESB 5629 (2) The awareness campaign must focus on increasing awareness of the prevalence of hepatitis B and hepatitis C, the potential treatments and cures for hepatitis B and hepatitis C, and aim to reduce the stigmas surrounding hepatitis B and hepatitis C.
or (d) The patient is receiving emergency medical service or designated trauma care service as defined in RCW 70.168.015.
(3) This section expires December 31, 2027.
(3)(a) If the patient accepts the offer of the hepatitis B screening test and the test is hepatitis B surface antigen (HBsAg) positive, the primary care provider shall offer the patient follow-up health care or refer the patient to another primary care provider who can provide follow-up health care.
Sec.
(b) If a patient accepts the offer of the hepatitis C screening test and the test is positive, the primary care provider shall offer the patient follow-up health care or refer the patient to another primary care provider who can provide follow-up health care.
3.
The follow-up health care shall include a hepatitis C diagnostic test (HCV RNA).
RCW 43.70.613 and 2021 c 276 s 2 are each amended to read as follows:
Show all 78 changed rows (38 more)
Previous
Latest
(4) The offering of a hepatitis B screening test and hepatitis C screening test under this section must be culturally and linguistically appropriate.
(1) By January 1, 2024, the rule-making authority for each health profession licensed under Title 18 RCW subject to continuing education requirements must adopt rules requiring a licensee to complete health equity continuing education training at least once every four years.
(5) This section does not affect the scope of practice of any primary care provider or diminish any authority or legal or professional obligation of any primary care provider to offer a hepatitis B screening test, hepatitis C screening test, or both, or a hepatitis C diagnostic test, or to provide services or care for the patient of a hepatitis B screening test, hepatitis C screening test, or both, or a hepatitis C diagnostic test.
(2) Health equity continuing education courses may be taken in addition to or, if a rule-making authority determines the course fulfills existing continuing education requirements, in place of other continuing education requirements imposed by the rule-making authority.
(6) A primary care provider that fails to comply with the requirements of this section shall not be subject to any disciplinary actions related to their licensure or certification, or to any civil or criminal liability, because of the primary care provider's failure to comply with the requirements of this section.
(3)(a) The secretary and the rule-making authorities must work collaboratively to provide information to licensees about available courses.
(7) The department may adopt rules necessary to implement this section and any additional rules involving the offering of screening tests and treatment requirements for hepatitis B and C and the training for primary care providers.
The secretary and rule-making authorities shall consult with patients or communities with lived experiences of health inequities or racism in the health care system and relevant professional organizations when developing the information and must make this information available by July 1, 2023.
(8) For purposes of this section, the following definitions apply:
The information should include a course option that is free of charge to licensees.
(a) "Follow-up health care" includes providing medical management and antiviral treatment for chronic hepatitis B or hepatitis C according to the latest national clinical practice guidelines p.
It is not required that courses be included in the information in order to fulfill the health equity continuing education requirement.
2 SB 5629 recommended by the American association for the study of liver diseases.
(b) By January 1, 2023, the department, in consultation with the boards and commissions, shall adopt model rules establishing the minimum standards for continuing education programs meeting the requirements of this section.
(b) "Hepatitis B screening test" includes any laboratory tests or tests that detect the presence of hepatitis B surface antigen (HBsAg) and provides confirmation of whether the patient has a chronic hepatitis B infection.
The department shall consult with patients or communities with lived experience of health inequities or racism in the health care system, relevant professional organizations, and the rule-making authorities in the development of these rules.
(c) "Hepatitis C diagnostic test" includes any laboratory test or tests that detect the presence of the hepatitis C virus in the blood and provides confirmation of whether the patient has an active hepatitis C virus infection.
(c) The minimum standards must include instruction on skills to address the structural factors, such as bias, racism, and poverty, that manifest as health inequities.
(d) "Hepatitis C screening test" includes any laboratory screening test or tests that detect the presence of hepatitis C virus antibodies in the blood and provides confirmation of whether the patient has ever been infected with the hepatitis C virus.
These skills include individual- level and system-level intervention, and self-reflection to assess p.
(e) "Primary care providers" includes general practice physicians, family practitioners, internists, pediatricians, osteopathic physicians, naturopaths, physician assistants, and advanced registered nurse practitioners licensed under this title.
4 ESB 5629 how the licensee's social position can influence their relationship with patients and their communities.
These skills enable a health care professional to care effectively for patients from diverse cultures, groups, and communities, varying in race, ethnicity, gender identity, sexuality, religion, age, ability, socioeconomic status, and other categories of identity.
The courses must assess the licensee's ability to apply health equity concepts into practice.
Course topics may include, but are not limited to:
(i) Strategies for recognizing patterns of health care disparities on an individual, institutional, and structural level and eliminating factors that influence them;
(ii) Intercultural communication skills training, including how to work effectively with an interpreter and how communication styles differ across cultures;
(iii) Implicit bias training to identify strategies to reduce bias during assessment and diagnosis;
(iv) Methods for addressing the emotional well-being of children and youth of diverse backgrounds;
(v) Ensuring equity and antiracism in care delivery pertaining to medical developments and emerging therapies;
(vi) Structural competency training addressing five core competencies:
(A) Recognizing the structures that shape clinical interactions;
(B) Developing an extraclinical language of structure;
(C) Rearticulating "cultural" formulations in structural terms;
(D) Observing and imagining structural interventions;
and (E) Developing structural humility;
((and)) (vii) Cultural safety training;
and (viii) Viral hepatitis screening and treatment, including courses related to recommendations from the federal centers for disease control and prevention and the United States preventive services task force.
(4) The rule-making authority may adopt rules to implement and administer this section, including rules to establish a process to determine if a continuing education course meets the health equity continuing education requirement established in this section.
(5) For purposes of this section the following definitions apply:
(a) "Rule-making authority" means the regulatory entities identified in RCW 18.130.040 and authorized to establish continuing p.
5 ESB 5629 education requirements for the health care professions governed by those regulatory entities.
(b) "Structural competency" means a shift in medical education away from pedagogic approaches to stigma and inequalities that emphasize cross-cultural understandings of individual patients, toward attention to forces that influence health outcomes at levels above individual interactions.
Structural competency reviews existing structural approaches to stigma and health inequities developed outside of medicine and proposes changes to United States medical education that will infuse clinical training with a structural focus.
(c) "Cultural safety" means an examination by health care professionals of themselves and the potential impact of their own culture on clinical interactions and health care service delivery.
This requires individual health care professionals and health care organizations to acknowledge and address their own biases, attitudes, assumptions, stereotypes, prejudices, structures, and characteristics that may affect the quality of care provided.
In doing so, cultural safety encompasses a critical consciousness where health care professionals and health care organizations engage in ongoing self- reflection and self-awareness and hold themselves accountable for providing culturally safe care, as defined by the patient and their communities, and as measured through progress towards achieving health equity.
Cultural safety requires health care professionals and their associated health care organizations to influence health care to reduce bias and achieve equity within the workforce and working environment.
3 SB 5629
6 ESB 5629
View plain text versions (2)

How this bill changes current law

1 change Share ↗

Compared against the Revised Code of Washington as published AI-generated reading aid — verify against the official bill.

This bill amends 1 section(s) of the Revised Code of Washington: RCW 43.70.613.

  • RCW 43.70.613

    and → how the licensee's social position can influence their relationship with patients and their communities. These skills enable a health care professional to care effectively for patients from diverse cultures, groups, and communities, varying in race, ethnicity, gender identity, sexuality, religion, age, ability, socioeconomic status, and other categories of identity. The courses must assess the licensee's ability to apply health equity concepts into practice. Course topics may include, but are not limited to: (i) Strategies for recognizing patterns of health care disparities on an individual, institutional, and structural level and eliminating factors that influence them; (ii) Intercultural communication skills training, including how to work effectively with an interpreter and how communication styles differ across cultures; (iii) Implicit bias training to identify strategies to reduce bias during assessment and diagnosis; (iv) Methods for addressing the emotional well-being of children and youth of diverse backgrounds; (v) Ensuring equity and antiracism in care delivery pertaining to medical developments and emerging therapies; (vi) Structural competency training addressing five core competencies: (A) Recognizing the structures that shape clinical interactions; (B) Developing an extraclinical language of structure; (C) Rearticulating "cultural" formulations in structural terms; (D) Observing and imagining structural interventions; and (E) Developing structural humility; (vii) Cultural safety training; and (viii) Viral hepatitis screening and treatment, including courses related to recommendations from the federal centers for disease control and prevention and the United States preventive services task force --- END ---

    amended

Action History

  1. By resolution, returned to Senate Rules Committee for third reading.

  2. First reading, referred to Health Care & Wellness.

  3. Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.

  4. Rules suspended. Placed on Third Reading.

  5. Floor amendment(s) adopted.

  6. Returned to second reading for amendment.

  7. Rules suspended.

  8. Placed on third reading by Rules Committee.

  9. By resolution, reintroduced and retained in present status.

  10. By resolution, returned to Senate Rules Committee for third reading.

  11. Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.

  12. First reading, referred to Health Care & Wellness.

  13. Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1.

  14. Rules suspended. Placed on Third Reading.

  15. Placed on second reading by Rules Committee.

  16. Passed to Rules Committee for second reading.

  17. Minority; without recommendation.

  18. HLTC - Majority; do pass.

  19. Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM.

  20. Public hearing in the Senate Committee on Health & Long Term Care at 8:00 AM.

  21. First reading, referred to Health & Long Term Care.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 146 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (146)

146 members have not signed on to this bill.

Show all 146 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed 49 Yea · 0 Nay
Party YeaNayPresentNot Voting
Unaffiliated 10000
Republican 16000
Democrat 23000
Total 49000
% of votes cast 100%0%0%0%
How each member voted (49)
Member Party Vote
Billig — Yea
Hawkins — Yea
Keiser — Yea
Kuderer — Yea
Mullet — Yea
Padden — Yea
Randall — Yea
Rivers — Yea
Van De Wege — Yea
Wilson, L. — Yea
Annette Cleveland Democrat Yea
Bob Hasegawa Democrat Yea
Claire Wilson Democrat Yea
Claudia Kauffman Democrat Yea
Derek Stanford Democrat Yea
Drew Hansen Democrat Yea
Jamie Pedersen Democrat Yea
Javier Valdez Democrat Yea
Jesse Salomon Democrat Yea
Joe Nguyen Democrat Yea
John Lovick Democrat Yea
June Robinson Democrat Yea
Lisa Wellman Democrat Yea
Liz Lovelett Democrat Yea
Manka Dhingra Democrat Yea
Marko Liias Democrat Yea
Noel Frame Democrat Yea
Rebecca Saldaña Democrat Yea
Sharon Shewmake Democrat Yea
Steve Conway Democrat Yea
T'wina Nobles Democrat Yea
Victoria Hunt Democrat Yea
Yasmin Trudeau Democrat Yea
Chris Gildon Republican Yea
Curtis King Republican Yea
Drew MacEwen Republican Yea
Jeff Holy Republican Yea
Jeff Wilson Republican Yea
Jim McCune Republican Yea
John Braun Republican Yea
Judy Warnick Republican Yea
Keith Wagoner Republican Yea
Mark Schoesler Republican Yea
Matt Boehnke Republican Yea
Nikki Torres Republican Yea
Perry Dozier Republican Yea
Phil Fortunato Republican Yea
Ron Muzzall Republican Yea
Shelly Short Republican Yea

Official roll call →

Passed 48 Yea · 0 Nay · 1 Other
Party YeaNayPresentNot Voting
Unaffiliated 11000
Republican 16000
Democrat 21001
Total 48001
% of votes cast 98%0%0%2%
How each member voted (49)
Member Party Vote
Billig — Yea
Hawkins — Yea
Keiser — Yea
Kuderer — Yea
Mullet — Yea
Padden — Yea
Randall — Yea
Rivers — Yea
Rolfes — Yea
Van De Wege — Yea
Wilson, L. — Yea
Annette Cleveland Democrat Yea
Bob Hasegawa Democrat Yea
Claire Wilson Democrat Yea
Claudia Kauffman Democrat Not Voting
Derek Stanford Democrat Yea
Jamie Pedersen Democrat Yea
Javier Valdez Democrat Yea
Jesse Salomon Democrat Yea
Joe Nguyen Democrat Yea
John Lovick Democrat Yea
June Robinson Democrat Yea
Lisa Wellman Democrat Yea
Liz Lovelett Democrat Yea
Manka Dhingra Democrat Yea
Marko Liias Democrat Yea
Noel Frame Democrat Yea
Rebecca Saldaña Democrat Yea
Sharon Shewmake Democrat Yea
Steve Conway Democrat Yea
T'wina Nobles Democrat Yea
Victoria Hunt Democrat Yea
Yasmin Trudeau Democrat Yea
Chris Gildon Republican Yea
Curtis King Republican Yea
Drew MacEwen Republican Yea
Jeff Holy Republican Yea
Jeff Wilson Republican Yea
Jim McCune Republican Yea
John Braun Republican Yea
Judy Warnick Republican Yea
Keith Wagoner Republican Yea
Mark Schoesler Republican Yea
Matt Boehnke Republican Yea
Nikki Torres Republican Yea
Perry Dozier Republican Yea
Phil Fortunato Republican Yea
Ron Muzzall Republican Yea
Shelly Short Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 5629?
SB 5629 is sponsored by Claire Wilson (Democrat), T'wina Nobles (Democrat), Bob Hasegawa (Democrat), Manka Dhingra (Democrat), and Steve Conway (Democrat).
What is the current status of SB 5629?
This bill died with 2023-2024 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 5629?
Track SB 5629 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 5629

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 5629

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →